| Company | Date | Position | Consensus ⓘ | Price Target ⓘ | 1-Yr Return |
|---|---|---|---|---|---|
|
TRIP
TripAdvisor
|
Jun 17, 2026 | BUY |
Hold
+97.0% avg upside
42 analysts
|
$20.00
54.27% Upside
|
+0.0% |
|
STAA
Staar Surgical
|
May 29, 2026 | BUY |
Hold
+14.2% avg upside
16 analysts
|
$40.00
37.30% Upside
|
-4.1% |
|
SOLV
Solventum Corporation
|
May 27, 2026 | BUY |
Buy
+14.1% avg upside
15 analysts
|
$94.00
24.64% Upside
|
-1.8% |
|
QBTS
D-Wave Quantum
|
May 13, 2026 | BUY |
Strong Buy
+47.6% avg upside
19 analysts
|
$40.00
62.09% Upside
|
+39.5% |
|
BUR
Burford Capital
|
May 11, 2026 | HOLD |
Strong Buy
+189.9% avg upside
7 analysts
|
$5.00
10.37% Upside
|
-3.5% |
|
CCRN
Cross Country Healthcare
|
May 08, 2026 | HOLD |
Hold
+20.0% avg upside
15 analysts
|
$13.25
0.51% Upside
|
-0.7% |
|
TASK
TaskUs
|
May 07, 2026 | BUY |
Buy
+301.8% avg upside
14 analysts
|
$12.00
144.45% Upside
|
-3.3% |
|
RITM
Rithm Capital
|
May 01, 2026 | BUY |
Strong Buy
+41.4% avg upside
16 analysts
|
$12.50
36.06% Upside
|
-5.3% |
|
HIMS
Hims & Hers Health
|
Aug 09, 2024 | HOLD |
Buy
-27.8% avg upside
22 analysts
|
$17.00
52.16% Downside
|
+225.4% |
|
NSSC
Napco Security Technologies
|
May 06, 2024 | BUY |
Strong Buy
+28.7% avg upside
8 analysts
|
$51.00
36.47% Upside
|
-44.7% |
|
SKIN
Beauty Health
|
Sep 19, 2023 | BUY |
Hold
+408.7% avg upside
11 analysts
|
$14.00
2012.29% Upside
|
-74.7% |
|
GETY
Getty Images Holdings
|
Aug 15, 2023 | BUY |
Buy
+1727.8% avg upside
7 analysts
|
$5.75
850.27% Upside
|
-21.6% |
|
SSTI
SoundThinking Inc
|
Aug 10, 2023 | BUY |
Strong Buy
+170.0% avg upside
15 analysts
|
$25.00
218.97% Upside
|
-22.5% |
|
HLLY
Holley
|
Aug 09, 2022 | BUY |
Strong Buy
+207.4% avg upside
13 analysts
|
$10.00
303.25% Upside
|
+0.3% |
Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.